Agenus Inc.
Anti-CTLA-4 antibodies and methods of use thereof
Last updated:
Abstract:
The instant disclosure provides antibodies that specifically bind to CTLA-4 (e.g., human CTLA-4) and antagonize CTLA-4 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
Status:
Grant
Type:
Utility
Filling date:
7 Dec 2017
Issue date:
25 May 2021